The other just delivered 28.7% body weight reduction in Phase 3 trials, numbers that rewrote what researchers thought was possible
Abstract The introduction of the highly potent incretin receptor agonists semaglutide and tirzepatide has marked a new era in the treatment of type 2 diabetes and obesity
She explains everything clearly, shes warm, funny, and supportive, and I feel genuinely cared for
Discontinuation due to side effects was slightly higher at the higher doses, up to 5.1%
Both incorporate glucagon receptor agonism alongside GLP-1 activity, but retatrutide takes this further by adding a third target -- GIP receptor agonism -- making it the first triple-hormone receptor agonist in clinical development
These multi-dimensional benefits suggest that retatrutide is more than a weight-loss drug